Profile data is unavailable for this security.
About the company
Celestial Biolabs Limited is an India-based biopharmaceutical company. The Company is engaged in the herbal and feed supplement formulations. Its product categories include herbals, enzymes and nutraceuticals. Its herbal products include proprietary products and classical products. Its proprietary products include BIOVITA, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, DERMACEL and others. The classical ayurvedic products are manufactured based on different pharmacopoeia (Ayurvedic Classical Texts). Its Classical products include Hingwastak Churna, Avipattikar Churna, Lavan Bhaskar Churna, Talishadi Churna, Sitopaladi Churna, Arogyavardhini Vati, Chandraprabha Vati, Triphala Churna and others. Its enzymes products include CELZYME-P, CELZYME-L, CELZYME-DMAX, CELZYME-OXI, CELZYME-TEXDS, CELZYME-TEXWASH, CELZYME-Bright and others. Its nutraceuticals products include Psyllium seed husk, Lycopene, Alpha lipoic acid, Fenugreek and others.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated1997
- Employees--
- LocationCelestial Biolabs LtdPlot No. 59Road No. 12, Apiic Tech ParkIda Nacharam, TelanganaHYDERABAD 500076IndiaIND
- Phone+91 4 023540008
- Fax+91 4 023542844
- Websitehttp://www.celestialbiolabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celestial Biolabs Limited | -100.00bn | -100.00bn | 44.36m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.80 | -- | 1.84 | -- | 42.38 | -- | 5.09 | -- | -- | -- | -- | 14.39 | 15.82 | -100.84 | -- | -- | -- |
Parenteral Drugs (India) Ltd | 84.96m | -763.62m | 86.47m | -- | -- | -- | -- | 1.02 | -25.61 | -25.61 | 2.85 | -276.37 | 0.0162 | 4.17 | 0.9266 | -- | -14.52 | -17.82 | -- | -- | 35.67 | 40.22 | -898.77 | -191.93 | 0.055 | -0.5192 | -- | -- | -30.17 | -48.70 | 37.26 | -- | -- | -- |